PCVX earnings: real EPS beat/miss history, analyst consensus Buy, P/E -8.13. Updated 2026-07-23.
Vaxcyte (PCVX) Research Hub
Vaxcyte (PCVX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 59.47 USD (-0.07%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.13, market cap 8.15B. This hub links to the full technical, earnings and options research available for PCVX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 59.47 USD (-0.07%) |
| 52-week range | 47.48 USD – 63.98 USD |
| Trend regime | Range |
| 14-day RSI | 55.6 (Bullish) |
| Trailing P/E | -8.13 |
| Market cap | 8.15B |
| Dividend yield | 0.00% |
Available research for PCVX
Covered Call on PCVX: how it works, illustrative setup around the real 59.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PCVX: how it works, illustrative setup around the real 59.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PCVX: how it works, illustrative setup around the real 59.47 USD price, max profit/loss, breakeven and when to use it. Educational.
PCVX technical analysis: range, last 59.47 USD, RSI 55.6, 52w range 47.48 USD–63.98 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PCVX in?
Vaxcyte (PCVX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PCVX in an uptrend or downtrend?
As of 2026-09-11, PCVX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PCVX's trailing P/E ratio?
PCVX's trailing P/E is -8.13, with a market cap of 8.15B. See the earnings research page for full valuation detail.